

Risk factors and predictors of neurological presentations in infections: definitions and cognitive bias (review)
Heading: Тhematic supplement Article type: Review
Authors: Kolokolov O.V., Kolokolova Т.О.
Organization: Moscow State Psychological and Pedagogical University, Saratov State Medical University
Objective: to analyze the clinical, psychological and methodological aspects of forming specialist's and the public's opinion about risk factors and predictors of nervous system's damage in infections. Publications in the electronic databases Google Scholar, PubMed, Springer and Elsevier for the period from 1933 to April 2022 using the keywords: «Infections», «Nervous system», «Risk factor», «Predictor», «COVID-19» were researched 39 literary sources were satisfying the search conditions. As a result of the analysis, it can be stated that there is currently no reliable information about the predictors of damage to the nervous system in COVID-19, and information about risk factors is contradictory. Previously accumulated experience (for example, during studying the infection caused by Treponema pallidum subsp. pallidum) can be useful in the analysis of information about new infections, in particular, caused by SARS-CoV-2. It is important to use the terms correctly to avoid cognitive bias. The interaction of doctors and psychologists is especially important during the pandemic period.
Bibliography:
1. Куваева И. О., Стрельникова A.M. Особенности совладания со специфической трудной ситуацией: пандемия COVID-19. Известия Уральского федерального университета. Сер. 1: Проблемы образования, науки и культуры 2021; 27 (2): 84-91.
2. Kahneman D. Thinking, fast and slow. N. Y: Farrar, Straus and Giroux, 2011; 499 p.
3. Kahneman D, Slovic P, Tversky A, eds. Judgment under uncertainty: heuristics and biases. Cambridge: Cambridge University Press, 2001; 555 p.
4. The United States National Library of Medicine (NLM). PubMed. URL: https://pubmed. ncbi.nlm.nih.gov/?term=lnfectio ns&sort=pubdate&size=50&show_snippets=off (10 Apr 2022).
5. Tony AA, Ahmed SBA, Tony EAE, et al. Predictors of neurological presentations of COVID-19 infected patients in South Egypt, Aswan Governorate: A single center study. Neuropsychiatr Dis Treat 2021; (17): 3471-82.
6. Aragao MFVV, Leal MC, Andrade PHP, et al. Clinical and radiological profiles of COVID-19 patients with neurological symptomatology: A comparative study. Viruses 2021; 13 (5): 845.
7. Au SCL. Comments on stroke as a neurological complication of COVID-19:Asystematicreviewandmeta-analysis of incidence, outcomes and predictors. J Stroke Cerebrovasc Dis 2021; 30 (10): 105863.
8. Flores-Silva FD, Garcia-Grimshaw M, Valdes-Ferrer SI, et al. Neurologic manifestations in hospitalized patients with COVID-19 in Mexico City. PLoS One 2021; 16 (4): e0247433.
9. Siow I, Lee KS, Zhang JJY, et al. Encephalitis as a neurological complication of COVID-19: A systematic review and meta-analysis of incidence, outcomes, and predictors. Eur J Neurol 2021; 28 (10): 3491-502.
10. Zare DehnaviA, Salehi M, ArabAhmadi M, et al. Clinical, laboratory and imaging characteristics of hospitalized COVID-19 patients with neurologic involvement: A cross-sectional study. Arch Acad Emerg Med 2022; 10 (1): e10.
11. Amanat M, Rezaei N, Roozbeh M, et al. Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID-19: A multicenter prospective clinical study. ВМС Neurol 2021; (21): 116.
12. Aragon-Benedi C, Oliver-Fornies P, Galluccio F, et al. Is the heart rate variability monitoring using the analgesia nociception index a predictor of illness severity and mortality in critically ill patients with COVID-19? A pilot study. PLoS One 2021; 16(3):e0249128.
13. Chachkhiani D, Soliman MY, Ваша D, etal. Neurological complications in a predominantly African American sample of COVID-19 predict worse outcomes during hospitalization. Clin Neurol Neurosurg 2020; (197): 106173.
14. Eskandar EN, Altschul DJ, de la Garza Ramos R, et al. Neurologic syndromes predict higher in-hospital mortality in COVID-19. Neurology 2021; 96 (11): e1527-38.
15. Garcia-Azorin D, Trigo J, Martinez-Pias E, et al. Neurological symptoms in COVID-19 patients in the emergency department. Brain Behav 2021; 11 (4): e02058.
16. Liotta EM, Batra A, Clark JR, et al. Frequent neurologic manifestations and encephalopathy-associated morbidity in COVID-19 patients. Ann Clin Transl Neurol 2020; 7 (11): 2221-30.
17. Martinot M, Eyriey M, Gravier S, et al. Predictors of mortality, ICU hospitalization, and extrapulmonary complications in COVID-19 patients. Infect Dis Now 2021; 51 (6): 518-25.
18. Pan Y, Yu Z, Yuan Y, et al. Alteration of autonomic nervous system is associated with severity and outcomes in patients with COVID-19. Front Physiol 2021; (12): 630038.
19. Zifko U, Schmiedlechner T, Saelens J, et al. COVID-19: involvement of the nervous system. Identifying neurological predictors defining the course of the disease. J Neurol Sci 2021; (425): 117438.
20. Chaumont H, Meppiel E, Roze E, et al. Long-term outcomes after NeuroCOVID: A 6-month follow-up study on 60 patients. Rev Neurol (Paris) 2022; 178 (1-2): 137-43.
21. Gordon I, Horesh D, Milstein N, et al. Pre-pandemic autonomic nervous system activity predicts mood regulation expectancies during COVID-19 in Israel. Psychophysiology 2021; 58 (11): e13910.
22. Jopling E, RnicK, Tracy A, LeMoult J. Impact of loneliness on diurnal cortisol in youth. Psychoneuroendocrinology 2021; (132): 105345.
23. Trigo J, Garcia-Azorin D, Planchuelo-Gomez Л, et al. Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: A retrospective cohort study. J Headache Pain 2020; 21 (1): 94.
24. Almeria M, Cejudo JC, Sotoca J, et al. Cognitive profile following COVID-19 infection: Clinical predictors leading to neuropsychological impairment. Brain Behav Immun Health 2020; (9): 100163.
25. Eden A, Simren J, Price RW, et al. Neurochemical biomarkersto study CNS effects of COVID-19: A narrative review and synthesis. J Neurochem 2021; (159): 61-77.
26. Liu JM, Tan BH, Wu S, et al. Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement, in the lethality of SARS-CoV-2 infection. J Med Virol 2021; (93): 1304-13.
27. Dadkhah M, Talei S, Doostkamel D, et al. The impact of COVID-19 on diagnostic biomarkers in neuropsychiatric and neuroimmunological diseases: A review. Rev Neurosci 2021; 33 (1): 79-92.
28. Gupta S, Chandra A, Ray BK, Pandit A. Treatment related fluctuation and response to intravenous immunoglobulin therapy in post COVID-19 Guillain-Barre syndrome. Diabetes Metab Syndr 2021; 15 (5): 102246.
29. Nersesjan V, Amiri M, Lebech AM, et al. Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up. J Neurol 2021; 268 (9): 3086-104.
30. Putilina MV, Grishin DV SARS-CoV-2 (COVID-19) as a predictor of neuroinflammation and neurodegeneration: potential therapy strategies. S.S. Korsakov Journal of Neurology and Psychiatry 2020; (120): 58-64.
31. Joshee S, Vatti N, Chang С. Long-Term Effects of COVID-19. Mayo Clin Proc 2022; (97): 579-99.
32. Margulis MS. Chronic infectious and parasitic diseases of the nervous system. Moscow; Leningrad: Medgiz, 1933; 388 p.
33. Reverby SM. More than fact and fiction. Cultural memory and the Tuskegee syphilis study. Hastings Cent Rep 2001; (31): 22-8.
34. Gonzalez H, Koralnik IJ, Marra CM. Neurosyphilis. Semin Neurol 2019; (39): 448-55.
35. Ho EL, Tantalo LC, Jones T, et al. Point-of-care treponemal tests for neurosyphilis diagnosis. Sex Transm Dis 2015; (42): 48-52.
36. Kolokolov OV. Damage to the nervous system in patients with syphilis: modern pathomorphosis, diagnosis and prevention: DSc diss. Moscow, 2013; 325 p.
37. Kolokolov OV, Tikhonova LA, Bakulev AL, et al. Syphilitic cerebral vasculitis: diagnostic possibilities. S. S. Korsakov Journal of Neurology and Psychiatry 2012; 112 (4): 11-17.
38. Bobrova LA. Cognitive distortions. Domestic and foreign literature. Series 3: Philosophy 2021; (2): 69-79.
39. Pokrovsky VI, Рак SG, Briko Nl, Danilkin BK. Infectious diseases and epidemiology. 3rd ed. Moscow: GEOTAR-Media, 2016; 1008 p.
Attachment | Size |
---|---|
2022_01-1_117-122.pdf | 314.94 KB |